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Abstract
A 40-year-old premenopausal female presented with foul-smelling per vaginal discharge for 3 months. Diagnostic 
work revealed a locally advanced primary malignant melanoma of uterine cervix. The patient declined pelvic surgery 
and was treated with Dacarbazine. Malignant melanoma is a rare tumour of skin and has been ranked in the top five 
cancers of Australia and Sweden. It is a tumour of melanocytes which forms melanin pigment in the skin. In men, the 
most common site is trunk while in females common site is limbs. However, melanoma can arise from mucosal surfaces 
where the melanocytes are present. Most common mucosal sites are head and neck followed by female genital tract.
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Introduction
Malignant melanoma is a rare tumour of skin and has 
been ranked in the top five cancers of Australia and 
Sweden.[1] Highest incidence has been reported from 
Queensland Australia.[2] There is a slight preponderance 
of males as compared to female as reported in one study 
of Pakistan.[3] Females most commonly develop these 
lesions on extremities while male usually on trunk and head 
and neck regions. No definite aetiology can be identified; 
however, it is found to be more in individuals exposed to 
sunlight. Interestingly, it does not have a direct relationship 
with the amount of sun exposure as is with other skin 
tumours because it is more common in white-collar workers 
than in those who work outdoors. Diagnosis is usually 
clinical, but histopathological confirmation is usually 
required. Special immunohistochemistry (IHC) stains, i.e., 
S-100, HMB-45, and Melan-A further helps in its diagnosis. 
The best treatment of melanoma is wide margin excision as 
it is radio and chemotherapy resistant. This middle age lady 
presented with unusual per vaginal foul-smelling discharge 
which on further workup was confirmed a case of primary 
malignant melanoma of cervix.
Case Report
A 40-year-old premenopausal female presented with 3 months 
history of foul-smelling per vaginal discharge. She was 
housewife with no comorbidities. Her exposure to the sun was 
not extraordinary. She had seven children, all by spontaneous 
vaginal delivery. Her youngest child was 7 years old.
The patient was initially seen by local general physicians 
and was started antifungal treatment with no improvement 
in symptoms. She was finally seen by a gynaecologist and 
advised ultrasonography. Ultrasound revealed a 7.5 cm 
× 5.5 cm mass in a lower uterine segment involving the 
anterior wall of the cervix. The differential diagnosis was 
a calcified fibroid or a malignant growth. Per speculum 
examination revealed a growth in uterine cervix involving 
upper two-third of the vagina. Biopsy of the mass revealed 
primary malignant melanoma of the cervix. IHC was 
positive for S-100, HMB-45 and Melan-A while negative 
for cytokeratin AE1/AE3, cytokeratin 5/6, p-63, Desmin, 
CD-99, lymphocyte common antigen, synaptophysin 
and vimentin. Magnetic resonance imaging (MRI) pelvis 
showed 5.8 cm × 8.0 cm × 6.5 cm (AP × TS × CC) mass 
involving proximal two-third of the vagina and the distal 
part of the cervix. The mass was extending into endocervix 
and endometrium causing its thickening. Anteriorly, it was 
causing an indentation on the posterior wall of the urinary 
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bladder with loss of intervening fat planes. Posterior, the 
mass was focally infiltrating into the anterior rectal wall 
[Figure 1]. Computed tomography scan chest/abdomen was 
negative for metastases. Disease was staged as International 
Federation of Gynecology and Obstetrics (FIGO) Stage IVA 
if staged on the lines of squamous cell carcinoma cervix.
The case was discussed in the city tumour board of 
Karachi. The patient refused surgery due to the risk of 
pelvic exenteration. Immunotherapy with ipilimumab was 
not feasible due to high cost. The option of radiotherapy 
was not considered due to the risk of rectovaginal fistula 
formation. Combination chemotherapy such as Cisplatin, 
Vinblastine and Dacarbazine was not considered due to 
a higher risk of toxicity with no survival benefit over the 
single agent. The patient was planned for six cycles of 
single agent Dacarbazine therapy (250 mg/m2) day 1–5 
Q4 weeks. However, the patient only received only three 
cycles and quit treatment.
Discussion
Malignant melanoma is a rare malignancy of skin. 
It accounts for only 2% of all skin malignancies. 
Predisposing factor is genetics, sun exposure, and multiple 
nevi. Prognosis of these case is usually poor if involving 
nodes or metastasizing to a distant site. Most common 
site of metastasis is a lung. Most common mucosal 
sites of involvement are head and neck followed female 
genital tract regions.[4] No definite treatment is available 
if the mass is irresectable. Most of the dermal melanoma 
are resectable, but this was a rare case where mass was 
at an unusual site and irresectable. It was irresectable 
due to its invasion into surrounding structures. Mucosal 
melanoma usually behaves aggressively. Their spread to a 
regional lymph node is quite early as compared to dermal 
melanoma and makes the condition of patient miserable 
if not resected well in time.
We reviewed the literature to check the total number case of 
cervical melanoma reported up till now. A total of 60 cases 
have been reported from different part of the world.[5] The 
latest report found was from Portugal published in 2011.[6]
Conclusion
Primary malignant melanoma of the cervix is rare and 
requires multidisciplinary management.
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Figure 1: Magnetic resonance imaging pelvis (sagittal view) 
showing the lesion of malignant melanoma in the cervix (arrow)
